ELTROMBOPAG 50 mg/1

Eltrombopag 50 mg tablets are a medication used to support platelet production. This oral treatment is commonly prescribed for conditions affecting blood cell counts.

Eltrombopag is primarily used to increase platelet counts in individuals with certain blood disorders. It is often prescribed for conditions where the body does not produce enough platelets, which are essential for blood clotting. Eltrombopag works by stimulating the bone marrow to produce more platelets, helping to reduce the risk of bleeding. What is Eltrombopag used for? It is typically used in the management of chronic immune thrombocytopenia (ITP) and other similar conditions.

Common effects of Eltrombopag may include mild gastrointestinal discomfort, such as nausea or diarrhea. Some individuals might experience headaches or dizziness. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Eltrombopag should be handled with care, especially for individuals with liver conditions. Regular monitoring of liver function may be recommended. It is important to follow the prescribed dosage and not to exceed it without medical advice. Always store the medication in a cool, dry place away from direct sunlight.

Eltrombopag may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be moderated, as it may affect the efficacy of the medication.